Merck & Co Inc (MRK) rated highest in P/E/Growth Investor model based on Peter Lynch's strategy.

From Nasdaq: 2025-05-20 09:44:00

Validea’s guru fundamental report for MERCK & CO INC (MRK) shows it rates highest using the P/E/Growth Investor model based on Peter Lynch’s strategy. With a rating of 93%, the stock is considered a large-cap value stock in the Biotechnology & Drugs industry. MRK meets the criteria for P/E/Growth ratio, sales and P/E ratio, inventory to sales, EPS growth rate, and total debt/equity ratio. Peter Lynch, a renowned mutual fund manager, has a common-sense approach to investing. Validea offers investment research services based on strategies from investment legends like Lynch, Warren Buffett, and Benjamin Graham.



Read more at Nasdaq: MRK Quantitative Stock Analysis – Peter Lynch